Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy.

R A Beveridge; J A Miller; A N Kales; R A Binder; N J Robert; J Heisrath-Evans; K Koczyk-Scripka; S Pashko; M J Norgard; H M Barnes

doi:10.1007/pl00009894

Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy.

Identifier:nobleid.org/w1/20260515/C3EB25B2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C3EB25B2.svg?ark=w1%2F20260515%2FC3EB25B2)](https://nobleid.org/work/w1/20260515/C3EB25B2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy.

Identifier:nobleid.org/w1/20260515/C3EB25B2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C3EB25B2.svg?ark=w1%2F20260515%2FC3EB25B2)](https://nobleid.org/work/w1/20260515/C3EB25B2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work